Over the next five years, the global CBD market is expected to accelerate to $23.6 billion, according to Grand View Research. All thanks to the growing adoption of CBD-infused products in industries such...
GW Pharmaceuticals (GWPH) Q4 results likely to reflect top-line growth on strong adoption of Epidiolex and Sativex.
InvestorsObserver issues critical PriceWatch Alerts for AMZN, BYND, FDX, GWPH, and TMUS.
In the latest trading session, GW Pharmaceuticals PLC (GWPH) closed at $115.46, marking a -0.06% move from the previous day.
In the latest trading session, GW Pharmaceuticals PLC (GWPH) closed at $113.64, marking a +1.81% move from the previous day.
GW Pharmaceuticals PLC (GWPH) closed the most recent trading day at $118.97, moving -0.13% from the previous trading session.
New Records Ahead of New Trade Deal and New Earnings Season
2020 is already a big year, we've got a presidential election, impeachment and Iranian incident. How's this going to effect our trading? It won't.
Here we discuss three best stocks in the emerging cannabis space.
The Zacks Analyst Blog Highlights: Innovative Industrial Properties, Aphria, Square and GW Pharmaceuticals
Marijuana legalization has started to ramp-up in several U.S. states. What's more, legalization of marijuana in the state of Illinois in January could bring positive tidings for the marijuana industry....
GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences, today...
GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences announced...
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
According to OrganiGram (OGI), there is hugely unmet consumer demand for CBD products.
New Records and New Milestones
Haemonetics (HAE) witnesses a steady uptick in Plasma franchise, fueled by favorable price, volume and mix.
GW Pharmaceuticals, NetGear, Cisco Systems and NetApp highlighted as Zacks Bull and Bear of the Day